Results 211 to 220 of about 577,742 (361)

Upfront Immunotherapy Approaches in the Management of Adults with Acute Lymphoblastic Leukemia. [PDF]

Cancers (Basel)
Shahzad M, Amin MK, Badar T.
europepmc   +1 more source

Asynchronous antigen expression in B lineage acute lymphoblastic leukemia [PDF]

, 1988
CA Hurwitz, MR Loken, ML Graham, JE Karp, MJ Borowitz, DJ Pullen, CI Civin   +6 more
openalex   +1 more source

Acute lymphoblastic leukemia

HemaSphere, 2018
openaire   +2 more sources

Improved outcomes in elderly patients with acute lymphoblastic leukaemia using a paediatric‐based protocol—A prospective study

British Journal of Haematology, EarlyView.
In this population‐based study the relapse rates were remarkably low in patients reaching day 79 with active treatment, challenging the widely accepted belief that ALL is difficult to cure in the elderly. Summary Population data have shown that the prognosis for elderly patients with acute lymphoblastic leukaemia (ALL) is poor, even in the modern era ...
P. Quist‐Paulsen, L. Horvei, J. Dalgaard, M. Moksnes, A. L. Eilertsen, M. Paulson, N. A. Azrakhsh, W. Majeed, H. S. Wik   +8 more
wiley   +1 more source

Population Pharmacokinetics and Covariate Analysis of Methotrexate in Pediatric Acute Lymphoblastic Leukemia. [PDF]

Drug Des Devel Ther
Yu B, Wan Y, Mei K, Zhan D, Tang Q, Hu X, Ji W, Cai H.   +7 more
europepmc   +1 more source

Histiocytic lymphoma fifteen years following remission of acute lymphoblastic leukemia [PDF]

, 1980
H Dosik, R Anon, SL Lee, AC Allen, M. Krishnamurthy   +4 more
openalex   +1 more source

Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party

British Journal of Haematology, EarlyView.
We retrospectively evaluated outcomes after a second haematopoietic stem cell transplantation (HSCT) performed between 2000 and 2022 for relapsed acute myeloid leukaemia in 345 children. We found that leukaemia‐free survival, overall survival, graft‐versus‐host disease (GVHD)/relapse‐free survival (GRFS) and relapse incidence improved over time, while ...
Nimrod Buchbinder, Victor Michel, Arnaud Dalissier, Katharina Kleinschmidt, Franco Locatelli, Alexei Maschan, Robert Wynn, Franca Fagioli, Marco Zecca, Charlotte Jubert, Birgitta Versluys, Petr Sedlacek, Ludmila Zubarovskaya, Marta Gonzalez Vicent, Alessandra Biffi, Gérard Michel, Oana Mirci‐Danicar, Wolfgang Holter, Marc Ansari, Jacques‐Emmanuel Galimard, Pascale Schneider, Mouad Abouqateb, Krzysztof Kałwak   +22 more
wiley   +1 more source

Combination of targeted pharmacotherapy and immunotherapy with anti-CD19 CAR NK cells in acute lymphoblastic leukemia. [PDF]

Hemasphere
Kirchhoff H, Schoenherr C, Fleischer L, Schweighart EK, Esser R, Talbot SR, Schambach A, Koehl U, Heidenreich O, Eder M, Scherr M.   +10 more
europepmc   +1 more source

Detection of the common acute lymphoblastic leukemia antigen in the serum of leukemia patients. [PDF]

, 1984
S Carrel, F. Buchegger, Didier Heumann, Christophe Girardet, C Barras, Gabriele A. Losa, Jean‐Pierre Mach, V von Fliedner   +7 more
openalex   +1 more source

Impact of methotrexate‐dosing regimens for GVHD prophylaxis on clinical outcomes of HLA‐matched allogeneic HSCT

British Journal of Haematology, EarlyView.
Summary Severe graft‐versus‐host disease (GVHD) remains a major complication of allogeneic haematopoietic stem cell transplantation (allo‐HSCT), necessitating optimal immunosuppressive strategies. This retrospective study used data from the Japanese Transplant Registry Unified Management Program to compare three methotrexate (MTX)‐dosing regimens for ...
Tomotaka Suzuki, Tomoyasu Jo, Kota Yoshifuji, Tadakazu Kondo, Noriko Doki, Yoshinobu Kanda, Tetsuya Nishida, Yasushi Onishi, Noboru Asada, Takahiro Fukuda, Masashi Sawa, Yuta Hasegawa, Kentaro Serizawa, Shuichi Ota, Masatsugu Tanaka, Makoto Yoshimitsu, Yoshiko Atsuta, Junya Kanda   +17 more
wiley   +1 more source